XV Eurasian Hematology-Oncology Congress - EHOC 2024
A

Luspatercept and Blood Transfusion Management in Beta Thalassemia and MDS

By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
By XV Eurasian Hematology-Oncology Congress - EHOC 2024 FEATURING Anıl Tombak
19 views
August 15, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

05:11
Pharmacosmos Hematology

A discussion on the safety of an IV iron replacement therapy

Feat. H. Bahrain

Featured Video

12:23
Hematology Content

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Feat. J. Bussel

Related Content

AUTOPLAY
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.3K views
15:39

Thalassemias: Overview of Pathophysiology and Treatment

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

K. Fertrin

1.0K views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.1K views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

686 views
17:38

Impact and Risks of Chronic Anemia in Thalassemia Patients

Farrukh Shah

606 views
16:09

Case-Based Discussion: Managing Non-Transfusion-Dependent Thalassemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Taher

1.5K views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

715 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

420 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

870 views
33:17

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

602 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

389 views
16:55

Making Sense of the New Classification Systems for MDS in 2024

Moffitt Cancer Center

R. Komrokji

444 views
04:54

New

Thalassemia: Overview of Pathophysiology and Risk for Malignancies

Ali Taher

192 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

327 views
12:15

Using Transplant in Patients With p53 Mutant MDS or AML

Moffitt Cancer Center

H. Elmariah

320 views
28:33

The Truth About Current Consensus Statements on Hematopoietic Cell T…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Gale

503 views
13:26

Chronic GvHD: Main Complications After ASCT

Steven Pavletic

363 views
32:04

Experts Discuss the Latest Data in Myeloid Diseases

Moffitt Cancer Center

A. Kuykendall, R. Komrokji, O. Chan, D. Sallman

547 views
09:42

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Pr…

2024 ASCO® Annual Meeting Insights Hub

M. Al Malki

270 views
25:38

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Rush University Medical Center

C. Brunstein

258 views